Edesa Biotech to Participate in Upcoming Investor ConferencesAccesswire • 24 days ago
TORONTO, ON / ACCESSWIRE / April 2, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
Share to Feed
Edesa Biotech, Inc. (NASDAQ:EDSA Get Free Report) CEO Pardeep Nijhawan purchased 5,000 shares of the companys stock in a transaction dated Monday, March 25th. The shares were bought at...
TORONTO, ON / ACCESSWIRE / March 21, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
TORONTO, ON / ACCESSWIRE / March 7, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
TORONTO, ON / ACCESSWIRE / March 4, 2024 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
Edesa Biotech, Inc. (NASDAQ:EDSA Free Report) Research analysts at HC Wainwright issued their Q2 2024 EPS estimates for shares of Edesa Biotech in a research note issued to investors...
Edesa Biotech (NASDAQ:EDSA Get Free Report)s stock had its buy rating restated by research analysts at HC Wainwright in a research report issued to clients and investors...
TORONTO, ON / ACCESSWIRE / February 9, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
Edesa Biotech, Inc. (NASDAQ:EDSA Free Report) Equities researchers at Brookline Capital Management issued their Q1 2024 earnings per share estimates for shares of Edesa Biotech in a...
Edesa Biotech, Inc. (NASDAQ:EDSA Free Report) Zacks Small Cap issued their Q1 2024 earnings per share estimates for Edesa Biotech in a report issued on Tuesday, January 2nd. Zacks...